Amazing how this bad news is released after the market closes ahead of a 3 day weekend!

https://finance.yahoo.com/news/sanofi-regener...00748.html

Sarilumab doesn't hit primary or secondary endpoints; trial stopped.


Read More: https://investorshangout.com/post/newpost/605...z6R5YWDujH